Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L S Mortensen

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Journal of Clinical Pathology|November 1, 1991
Tuberous sclerosis and parathyroid adenomaL S Mortensen, J Rungby
Acta Oncologica (Stockholm, Sweden)|January 1, 1997
On the importance of sensitivity to the dose-effect relationship in chemotherapyA Jakobsen, L S Mortensen
American Heart Journal|July 17, 1998
Comparison of the prognosis after early versus late recurrent nonfatal myocardial infarction. DAVIT Study Group. Danish Verapamil Infarction TrialA Sajadieh, J F Hansen, L S Mortensen
Danish Medical Bulletin|December 1, 1978
Evaluation of prognosisE Kjøller, L S Mortensen, M E Larsen
Cardiovascular Drugs and Therapy|November 24, 1998
Temporal pattern of the effect of verapamil on myocardial reinfarction. DAVIT Study Group. Danish Verapamil Infarction TrialA Sajadieh, J F Hansen, L S Mortensen
Ugeskrift for Laeger|February 26, 2000
[Prognosis after late versus early nonfatal myocardial infarction]A Sajadieh, J F Hansen, L S Mortensen
Ugeskrift for Laeger|August 20, 1990
[Thrombocyte concentrate infusions--a study of the frequency of contamination and its clinical significance]L S Mortensen, K D Christensen, J Jørgensen
European Heart Journal|February 1, 1994
The prognostic significance of post-infarction angina pectoris and the effect of verapamil on the incidence of angina pectoris and prognosis. The Danish Study Group on Verapamil in Myocardial InfarctionC M Jespersen, J F Hansen, L S Mortensen
The American Journal of Cardiology|April 24, 1999
Nonsteroidal anti-inflammatory drugs after acute myocardial infarction. DAVIT Study Group. Danish Verapamil Infarction TrialA Sajadieh, O Wendelboe, J F Hansen, et al.
European Heart Journal|May 23, 1998
5993 survivors of suspected myocardial infarction. 10 year incidence of later myocardial infarction and subsequent mortalityS Galatius, J Launbjerg, L S Mortensen, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Journal of Clinical Pathology|November 1, 1991
Tuberous sclerosis and parathyroid adenomaL S Mortensen, J Rungby
Acta Oncologica (Stockholm, Sweden)|January 1, 1997
On the importance of sensitivity to the dose-effect relationship in chemotherapyA Jakobsen, L S Mortensen
American Heart Journal|July 17, 1998
Comparison of the prognosis after early versus late recurrent nonfatal myocardial infarction. DAVIT Study Group. Danish Verapamil Infarction TrialA Sajadieh, J F Hansen, L S Mortensen
Danish Medical Bulletin|December 1, 1978
Evaluation of prognosisE Kjøller, L S Mortensen, M E Larsen
Cardiovascular Drugs and Therapy|November 24, 1998
Temporal pattern of the effect of verapamil on myocardial reinfarction. DAVIT Study Group. Danish Verapamil Infarction TrialA Sajadieh, J F Hansen, L S Mortensen
Ugeskrift for Laeger|February 26, 2000
[Prognosis after late versus early nonfatal myocardial infarction]A Sajadieh, J F Hansen, L S Mortensen
Ugeskrift for Laeger|August 20, 1990
[Thrombocyte concentrate infusions--a study of the frequency of contamination and its clinical significance]L S Mortensen, K D Christensen, J Jørgensen
European Heart Journal|February 1, 1994
The prognostic significance of post-infarction angina pectoris and the effect of verapamil on the incidence of angina pectoris and prognosis. The Danish Study Group on Verapamil in Myocardial InfarctionC M Jespersen, J F Hansen, L S Mortensen
The American Journal of Cardiology|April 24, 1999
Nonsteroidal anti-inflammatory drugs after acute myocardial infarction. DAVIT Study Group. Danish Verapamil Infarction TrialA Sajadieh, O Wendelboe, J F Hansen, et al.
European Heart Journal|May 23, 1998
5993 survivors of suspected myocardial infarction. 10 year incidence of later myocardial infarction and subsequent mortalityS Galatius, J Launbjerg, L S Mortensen, et al.
Pageof 4